HIV-Associated Neurocognitive Disorder: Pathogenesis and Therapeutic Opportunities

Journal of NeuroImmune Pharmacology - United States
doi 10.1007/s11481-010-9205-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Host Genetic Factors Predisposing to HIV-Associated Neurocognitive Disorder

Current HIV/AIDS Reports
VirologyInfectious Diseases
2014English

P218 Determining the Neurocognitive Status and Functional Ability to Screen for HIV-associated Neurocognitive Disorder (HAND)

2019English

Neural Dynamics of Selective Attention Deficits in HIV-associated Neurocognitive Disorder

Neurology
Neurology
2018English

Characteristics of Resting-State Functional Connectivity in HIV-Associated Neurocognitive Disorder

PLoS ONE
Multidisciplinary
2016English

Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis

Frontiers in Neuroscience
Neuroscience
2019English

Controversies in HIV-associated Neurocognitive Disorders

The Lancet Neurology
Neurology
2014English

HIV-1 Tat Increases BAG3 via NF-κB Signaling to Induce Autophagy During HIV-associated Neurocognitive Disorder

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2018English

Prediction of HIV-associated Neurocognitive Disorder (HAND) From Three Genetic Features of Envelope Gp120 Glycoprotein

Retrovirology
VirologyInfectious Diseases
2018English

Expression of CHRFAM7A and CHRNA7 in Neuronal Cells and Postmortem Brain of HIV-infected Patients: Considerations for HIV-associated Neurocognitive Disorder

Journal of NeuroVirology
VirologyNeurologyCellularMolecular Neuroscience
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy